- Owners of cats for which Mirataz® is prescribed will be required to sign an owner consent prior to participation.
- Participating veterinary clinics will be asked to complete two online questionnaires: 1) at the time Mirataz® is prescribed (INITIAL), and 2) following a 14 day treatment period (14 DAY). This includes answers to questions that need to be collected from the owner.
- If Mirataz® is prescribed again after the initial 14 day treatment period, optional questionnaires at 1 month (1MONTH) and 3 months (3MONTH) may be completed.
- The online questionnaires are to be completed by a clinic staff member which may be the veterinarian, veterinary technician/nurse, or other veterinary staff member.
Cats are prescribed Mirataz® at the discretion of the attending veterinarian and according to labeled instructions. Please visit KindredBio.com/mirataz-pi for full prescribing information. Cats may be removed from participation at any time, either at the will of the owner or upon recommendation by the attending veterinarian.
Step 1 – Enroll Your Practice
Step 2 – Log In and Enroll a Cat or Submit a Questionnaire
Mirataz® (mirtazapine transdermal ointment) is indicated for the management of weight loss in cats
Important Safety Information
Mirataz® (mirtazapine transdermal ointment) is for topical use in cats only under veterinary supervision. Do not use in cats with a known hypersensitivity to mirtazapine or any of the excipients. Do not use in cats treated with monoamine oxidase inhibitors (MAOIs). Not for human use. Keep out of reach of children. Wear gloves when handling/applying, wash hands after and avoid contact between the treated cat and people or other animals for 2 hours following application. Use with caution in cats with hepatic and kidney disease. Cat’s food intake should be monitored upon discontinuation. Safety has not been evaluated in cats less than 2 kg, less than six months of age or in breeding, pregnant or lactating cats. The most common adverse reactions observed during clinical trials were application site reactions, behavioral abnormalities (vocalization and hyperactivity) and vomiting.
For product label, including complete safety information please visit KindredBio.com/mirataz-pi, or contact KindredBio Professional Services at 888-608-2542.
Technical Information for your Clinic
Resources for Veterinarian to Provide to Pet Owners
As this is commercial product, which is purchased and prescribed at your discretion, to report a suspected adverse event or product quality complaint please call 1-888-608-2542 or email ProfessionalServices@KindredBio.com
Mirataz is a registered trademark of Kindred Biosciences, Inc. in the United States and/or other countries. ©2018 Kindred Biosciences, Inc., Burlingame, CA 94010. All rights reserved.